Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

By Aas T.   Geisler S.   Eide G.E.   Haugen D.F.   Varhaug J.E.   Bassoe A.M.   Thorsen T.   Berntsen H.   Borresen-Dale A.-L.   Akslen L.A.   Lonning P.E.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 438-446

Elsevier

Access to resources Recommend Favorite

Predictive value of phosphorylated mammalian target of rapamycin for diseasefree survival in breast cancer patients receiving neoadjuvant chemotherapy

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2642-2648

Spandidos Publications

Access to resources Recommend Favorite

BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis

By                        

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 141-145

Spandidos Publications

Access to resources Recommend Favorite

Predictive Immunohistochemical Biomarkers in the Context of Neoadjuvant Therapy for Breast Cancer

By Generali Daniele   Symmans William F.   Berruti Alfredo   Fox Stephen B.  

Journal of the National Cancer Institute Monographs, Vol. 2011, Iss. 43, 2011-10 ,pp. : 99-102

Oxford University Press

Access to resources Recommend Favorite

TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy

By Wang Jiayu  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 531-537

Springer Publishing Company

Access to resources Recommend Favorite